AAAAAA
Results: 26-36/36
Authors:
Ueda, Y
Yamagishi, H
Tanioka, Y
Fujiwara, H
Fuji, N
Itoh, T
Fujiki, H
Yoshimura, T
Oka, T
Citation: Y. Ueda et al., Clinical application of adoptive immunotherapy and IL-2 for the treatment of advanced digestive tract cancer, HEP-GASTRO, 46, 1999, pp. 1274-1279
Authors:
Hecker, E
Hoffken, K
Fujiki, H
Citation: E. Hecker et al., His Imperial Highness Prince Hitachi, J CANC RES, 125(3-4), 1999, pp. 121-122
Authors:
Fujiki, H
Suganuma, M
Citation: H. Fujiki et M. Suganuma, Unique features of the okadaic acid activity class of tumor promoters, J CANC RES, 125(3-4), 1999, pp. 150-155
Authors:
Fujiki, H
Citation: H. Fujiki, Two stages of cancer prevention with green tea, J CANC RES, 125(11), 1999, pp. 589-597
Authors:
Fujiki, H
Suganuma, M
Okabe, S
Sueoka, E
Suga, K
Imai, K
Nakachi, K
Kimura, S
Citation: H. Fujiki et al., Mechanistic findings of green tea as cancer preventive for humans, P SOC EXP M, 220(4), 1999, pp. 225-228
Authors:
Orito, K
Imaizumi, T
Yoshida, K
Fujiki, H
Kishi, M
Teramoto, S
Tanaka, M
Shimizu, H
Tominaga, M
Kimura, Y
Kambayashi, J
Mori, T
Citation: K. Orito et al., Mechanisms of action of OPC-28326, a selective hindlimb vasodilator, J PHARM EXP, 291(2), 1999, pp. 604-611
Authors:
Fujiki, H
Citation: H. Fujiki, The structure of rice production in Japan and Taiwan, ECON DEV CU, 47(2), 1999, pp. 387-400
Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers
Authors:
Sueoka, E
Goto, Y
Sueoka, N
Kai, Y
Kozu, T
Fujiki, H
Citation: E. Sueoka et al., Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers, CANCER RES, 59(7), 1999, pp. 1404-1407
Authors:
Suganuma, M
Okabe, S
Marino, MW
Sakai, A
Sueoka, E
Fujiki, H
Citation: M. Suganuma et al., Essential role of tumor necrosis factor alpha (TNP-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice, CANCER RES, 59(18), 1999, pp. 4516-4518
Authors:
Suganuma, M
Okabe, S
Kai, Y
Sueoka, N
Sueoka, E
Fujiki, H
Citation: M. Suganuma et al., Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9, CANCER RES, 59(1), 1999, pp. 44-47
Authors:
Sueoka, E
Sueoka, N
Kai, Y
Okabe, S
Suganuma, M
Kanematsu, K
Yamamoto, T
Fujiki, H
Citation: E. Sueoka et al., Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappa B activation, BIOC BIOP R, 252(3), 1998, pp. 566-570